Icapamespib
- Generic Name
- Icapamespib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23IN6O2S
- CAS Number
- 1000999-96-1
- Unique Ingredient Identifier
- 447591A1PU
- Associated Conditions
- -
- Associated Therapies
- -
Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Samus Therapeutics, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT04782609
- Locations
- 🇺🇸
University of California, Las Angeles Medical Center, Los Angeles, California, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath